CRMD Q3 2020 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$518M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$93,020+56.3% YoY

Gross Profit

$13,10714.1% margin

Operating Income

-$7M-7099.3% margin

Net Income

-$7M-7096.1% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

+465.7%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$611,440

Balance Sheet

Total Assets

$40M

Total Liabilities

$6M

Stockholders' Equity

$34M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$93,020	$59,530	+56.3%
Gross Profit	$13,107	-$19,496	+167.2%
Operating Income	-$7M	-$5M	-27.7%
Net Income	-$7M	-$5M	-25.4%